Low-dose chronic lead exposure increases systolic arterial pressure and vascular reactivity of rat aortas

Free Radical Biology and Medicine

Volumn 67, Issue , 2014, Pages 366-376

  Silveira, Edna Aparecida ^a   Siman, Fabiana Dayse Magalhães ^a   De Oliveira Faria, Thaís ^a   Vescovi, Marcos Vinícius Altoé ^a   Furieri, Lorena Barros ^a   Lizardo, Juliana Hott Fúcio ^a   Stefanon, Ivanita ^a   Padilha, Alessandra Simão ^a   Vassallo, Dalton Valentim ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Free radicals; Hypertension; Lead acetate; Local renin angiotensin system; NO; Rat aorta; ROS; Vasoconstrictor prostanoids

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; ACETYLCHOLINE; ANGIOTENSIN RECEPTOR; APOCYNIN; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FUREGRELATE; HYDROGEN PEROXIDE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LEAD ACETATE; LOSARTAN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM CHLORIDE; PROSTAGLANDIN SYNTHASE; PROSTANOID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SUPEROXIDE DISMUTASE; ACETOPHENONE DERIVATIVE; ANTIOXIDANT; CYCLOOXYGENASE 2 INHIBITOR; PROSTAGLANDIN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; BIOAVAILABILITY; BLOOD VESSEL REACTIVITY; CARDIOTOXICITY; CONTROLLED STUDY; HEART CONTRACTION; HYPERTENSION; LEAD BLOOD LEVEL; LONG TERM EXPOSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTOLIC BLOOD PRESSURE; VASCULAR RING; VASOCONSTRICTION; VASODILATATION; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; MALE; ANIMAL; AORTA; BLOOD PRESSURE; CHRONIC DISEASE; DRUG EFFECTS; LEAD POISONING; METABOLISM; PATHOPHYSIOLOGY; VASCULAR RESISTANCE; WISTAR RAT;

ACETOPHENONES; ANIMALS; ANTIOXIDANTS; AORTA; BLOOD PRESSURE; CHRONIC DISEASE; CYCLOOXYGENASE 2 INHIBITORS; INDOMETHACIN; LEAD POISONING; LOSARTAN; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; PROSTAGLANDINS; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM; SUPEROXIDE DISMUTASE; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 84890904616     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.11.021     Document Type: Review

References (50)

1. N.D. Vaziri Mechanisms of lead-induced hypertension and cardiovascular disease Am. J. Physiol. Heart Circ. Physiol. 295 2008 H454 H465
2. E. Den Hond, T. Nawrot, and J.A. Staessen The relationship between blood pressure and blood lead in NHANES III National Health and Nutritional Examination Survey J. Hum. Hypertens. 16 2002 563 568
3. L. Patrick Lead toxicity, a review of the literature. Part I. Exposure, evaluation, and treatment Altern. Med. Rev. 11 2006 2 22
4. A. Navas-Acien, B.S. Schwartz, S.J. Rothenberg, H. Hu, E.K. Silbergeld, and E. Guallar Bone lead levels and blood pressure endpoints: a meta-analysis Epidemiology 19 2008 496 504
5. M. Carmignani, P. Boscolo, A. Poma, and A.R. Volpe Kininergic system and arterial hypertension following chronic exposure to inorganic lead Immunopharmacology 44 1999 105 110
6. M. Marques, I. Millás, A. Jiménes, E. Gárcia-Colis, and J.A. Rodrigues-Feo et al. Alteration of the soluble guanylate cyclase system in the vascular wall of lead induced hypertension in rats J. Am. Soc. Nephrol. 12 2001 2594 2600
7. D.V. Vassallo, E.C. Lebarch, C.M. Moreira, G.A. Wiggers, and I. Stefanon Lead reduces tension development and the myosin ATPase activity on the right ventricular myocardium Braz. J. Med. Biol. Res. 41 2008 789 795
8. E.A. Silveira, J.H.F. Lizardo, L.P. Souza, I. Stefanon, and D.V. Vassallo Acute lead-induced vasoconstriction in the vascular beds of isolated perfused rat tails is endothelium-dependent Braz. J. Med. Biol. Res. 43 2010 492 499
9. J. Fiorim, Ribeiro, R.F. Júnior, E.A. Silveira, A.S. Padilha, M.V. Vescovi, H.C. de Jesus, A.S. Padilha, I. Stefanon, M. Salaices, and D.V. Vassallo Low-level lead exposure increases systolic arterial pressure and endothelium derived vasodilator factors in rat aortas PLoS One 6 2011 e17117
10. R. Renner Out of plumb: when water treatment causes lead contamination Environ. Health Perspect. 117 2009 A542 A547
11. E. Weiler, F. Khalil-Manesh, and H. Gonick Effects of lead and natriuretic hormone on kinetic of sodium potassium ATPase: possible relevance to hypertension Environ. Health Perspect. 78 1988 113 115
12. F. Piccinini, L. Favalli, and M.C. Chiari Experimental investigations on the contraction induced by lead in arterial smooth muscle Toxicology 8 1977 43 51
13. F. Khalil-Manesh, H.C. Gonick, E.W. Weiler, B. Prins, M.A. Weber, and R.E. Purdy Lead-induced hypertension: possible role of endothelial factors Am. J. Hypertens. 6 1993 723 729
14. H.R. Chang, S.S. Chen, D.A. Tsao, J.T. Cheng, C.K. Ho, and H.S. Yu Reduced vascular beta-adrenergic receptors and catecholamine response in rats with lead induced hypertension Arch. Toxicol. 71 1997 778 781
15. D.A. Tsao, H.S. Yu, J.T. Cheng, C.K. Ho, and H.R. Chang The change of β-adrenergic system in lead-induced hypertension Toxicol. Appl. Pharmacol. 163 2000 127 133
16. S.W. Watts, S. Chai, and C.R. Webb Lead acetate-induced contraction in rabbit mesenteric artery: interaction with calcium and protein kinase C Toxicology 99 1995 55 65
17. M.A. Sharifi, R. Darabi, N. Akbarloo, B. Larijani, and A. Khoshbaten Investigation of circulatory and tissue ACE activity during development of lead-induced hypertension Toxicol. Lett. 153 2004 233 238
18. N.D. Vaziri, Y. Ding, and Z. Ni Nitric oxide synthase expression in the course of lead-induced hypertension Hypertension 34 1999 558 562
19. Agency for Toxic Substances and Disease Registry Toxicological profile for lead 2005 U.S. Department of Health and Human Services, Public Health Service Atlanta
20. M.J. Kosnett, R.P. Wedeen, S.J. Rothenberg, K.L. Hipkins, B.L. Materna, B.S. Schwartz, H. Hu, and A. Woolf Recommendations for medical management of adult lead exposure Environ. Health Perspect. 115 2007 463 471
21. R. Ehrlich, T. Robins, E. Jordaan, S. Miller, S. Mbuli, P. Selby, S. Wynchank, A. Cantrell, M. De Broe, P. D'Haese, A. Todd, and P. Landrigan Lead absorption and renal dysfunction in a South African battery factory Occup. Environ. Med. 55 1998 453 460
22. S.B. Glenn, W.F. Stewart, J.M. Links, A.C. Todd, and B.S. Schwartz The longitudinal association of lead with blood pressure Epidemiology 14 2003 30 36
23. L.T. Grizzo, and S. Cordellini Perinatal lead exposure affects nitric oxide and cyclooxygenase pathways in aorta of weaned rats Toxicol. Sci. 103 2008 207 214
24. J. Koresková-Sysalová Determination of cadmium and lead levels in human blood of a general Czech population by GAAS Biol. Trace Elem. Res. 56 1997 321 329
25. M.C. Martín, G. Balfagón, N. Minoves, J. Blanco-Rivero, and M. Ferrer Androgen deprivation increases neuronal nitric oxide metabolism and its vasodilator effect in rat mesenteric arteries Nitric Oxide 12 2005 163 176
26. W.R. Harlan The relationship of blood lead levels to blood pressure in the U.S. population Environ. Health Perspect. 78 1988 9 13
27. A. Navas-Acien, E. Guallar, E.K. Silbergeld, and S.J. Rothenberg Lead exposure in cardiovascular disease - a systematic review Environ. Health Perspect. 115 2007 472 482
28. M. Lustberg, and E. Silbergeld Blood lead levels and mortality Arch. Intern. Med. 162 2002 2443 2449
29. M. Carmignani, A.R. Volpe, P. Boscolo, N. Qiao, M. Di Gioacchino, A. Grilli, and M. Felaco Catecholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment Life Sci. 68 2000 401 415
30. S. Kasperczyk, A. Kasperczyk, A. Ostalowska, M. Dziwisz, and E. Birkner Activity of glutathione peroxidase, glutathione reductase, and lipid peroxidation in erythrocytes in workers exposed to lead Biol. Trace Elem. Res. 102 2004 61 72
31. F. Farmand, A. Ehdaie, C.K. Roberts, and R.K. Sindhu Lead-induced dysregulation of superoxide dismutases, catalase, glutathione peroxidase, and guanylate cyclase Environ. Res. 98 2005 33 39
32. M.R. Simões, R.F. Ribeiro Júnior, M.V.A. Vescovi, H.C. de Jesus, A.S. Padilha, I. Stefanon, D.V. Vassallo, M. Salaices, and M. Fioresi Acute lead exposure increases arterial pressure: role of the renin-angiotensin system PLoS One 6 2011 e18730
33. R.C. Webb, R.J. Winquist, W. Victery, and A. Vander In vivo and in vitro effects of lead on vascular reactivity in rats Am. J. Physiol. 241 1981 H211 H216
34. A. Heydari, A. Norouzzadeh, A. Khoshbaten, A. Asgari, A. Ghasemi, S. Najafi, and R. Badalzadeh Effects of short term and subchronic lead poisoning on nitric oxide metabolites and vascular responsiveness in rat Toxicol. Lett. 166 2006 88 94
35. N.D. Vaziri, Y. Ding, and H.C. Gonick Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effects of lazoroid therapy Kidney Int. 52 1997 1042 1046
36. G. Karimi, A. Khoshbaten, M. Abdollahi, M. Sharifzadeh, and K. Namiranian Effects of subacute lead acetate administration on nitric oxide and cyclooxygenase pathways in rat isolated aortic ring Pharmacol. Res. 46 2002 31 37
37. A. Virdis, A. Bacca, R. Colucci, E. Durant, M. Fornai, G. Materazzi, C. Ippolito, N. Bernardini, C. Blandizzi, G. Bernini, and S. Taddei Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation Hypertension 62 2013 337 344
38. +2) exposure Toxicol. Lett. 186 2009 78 83
39. F. Barbosa Jr, J.T. Sertorio, R.F. Gerlach, and J.E. Tanus-Santos Clinical evidence for lead-induced inhibition of nitric oxide formation Arch. Toxicol. 80 2006 811 816
40. M. Hermes-Lima, B. Pereira, and E.J.H. Bakery Are free radicals involved in lead poisoning? Xenobiotica 21 1991 1085 1090
41. A.R. Weseler, and A. Bast Oxidative stress and vascular function: implications for pharmacology treatment Curr. Hypertens. Rep. 12 2010 154 161
42. D.A. Fox, L. He, A.T. Poblenz, C.J. Medrano, Y.S. Blocker, and D. Srivastava Lead-induced alterations in retinal cGMP phosphodiesterase trigger calcium overload, mitochondrial dysfunction and Rod photoreceptor apoptosis Toxicol. Lett. 102-103 1998 359 361
43. L. Wang, H. Wang, M. Hu, J. Cao, D. Chen, and A. Liu Oxidative stress and apoptotic changes in primary cultures of rat proximal tubular cells exposed to lead Arch. Toxicol. 83 2009 417 427
44. Z. Ni, S. Hou, C.H. Barton, and N.D. Vaziri Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells Kidney Int. 66 2004 2329 2336
45. N.D. Vaziri, C.Y. Lin, F. Farmand, K. Ram, and R.K. Sindhu Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension Kidney Int. 63 2003 186 194
46. A.S. Adeagbo, X. Zhang, D. Patel, I.G. Joshua, Y. Wang, X. Sun, I.N. Igbo, and M.A. Oriowo Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension J. Hypertens. 23 2005 1025 1036
47. S.L. Wong, F.P. Leung, C.W. Lau, C.L. Au, L.M. Yung, X. Yao, Z.Y. Chen, P.M. Vanhoutte, M. Gollasch, and Y. Huang Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium dependent contractions in the aorta of hamsters with increased impact during aging Circ. Res. 104 2009 228 235
48. P.K. Mehta, and K.K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am. J. Physiol. Cell Physiol. 292 2007 C82 C97
49. Y. Álvarez, J.V. Perez-Giron, R. Hernanz, A.M. Briones, A.G. Redondo, A. Beltrán, M.J. Alonso, and M. Salices Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats J. Pharmacol. Exp. Ther. 321 2007 381 388
50. A.E. Beltrán, A.M. Briones, A.B. Garcia-Redondo, C. Rodríguez, M. Miguel, Y. Alvarez, M.J. Alonso, J. Martínez- González, and M. Salaices p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats J. Hypertens. 27 2009 142 154